Episode 20: Unified Insights — Bridging the R&D Data Divide

Discover the future lab, an ecosystem where digital transformations shape the landscape of biopharma research, driving innovation and unlocking the potential of tomorrow's therapies.

Data silos and challenges around data fragmentation and interoperability hinder holistic insights and innovation in R&D. Employing strategy around the patient at the center of data interoperability can provide accelerated insights and innovation through a unified approach to data management.

Historically, cancer drug development has a high failure rate. Why is that, and how can we facilitate success? Listen in as we chat with the co-founder of a company that is trying to shift the paradigm using AI and machine learning.

From antibiotics to cancer drugs, fungi and other microbes have long been a rich source of medicinal compounds. In this episode, we discuss how one company sequences and mines novel fungal genomes to discover and engineer new therapeutics.

Early detection of cancer and other diseases can significantly improve patient prognosis. Join us for a practical discussion about the challenges of developing noninvasive early screening tools, from biomarker identification to clinical performance.

Precision medicine is a multifaceted approach to designing and delivering individualized patient treatments. Using multi-omic, environmental, lifestyle, and other data, researchers aim to more accurately develop treatment and prevention strategies tailored to each unique patient. The promise of precision medicine is huge, but it also creates new challenges around data capture, storage, computation, and creation of algorithms for prediction and analysis. In this episode, we discuss the evolution of precision medicine and some ways these challenges are and can be addressed, including blockchain, remote patient monitoring, and strategic data integration. Guest: Kumar Bala, Former Head of Digitalomics Strategy, Oracle

The relatively high failure rate of new candidate drugs is a key issue in pharma and biopharma R&D. Listen in as we discuss how artificial intelligence, machine learning, and the ever-increasing availability of biological datasets can improve prospects.

Digital therapeutics are software-driven, evidence-based healthcare products. They can improve patient access to and involvement in their care, improving outcomes. Join us as we discuss the recent rise in digital therapeutics and what the future may hold.

Personalized medicine is critical to the future of healthcare. However, implementation faces unique challenges. What changes are needed for personalized medicine to truly become a reality? What are some of the biggest obstacles? Listen in as we discuss.

High-throughput technologies have triggered a surge in scientific data generation and consumption, but managing these volumes of data is challenging. Listen as we discuss data fabric, an emerging solution that connects data sources in one environment.